HRT Financial’s Wave Life Sciences WVE Stock Holding History

HRT Financial’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$255K	Buy	44,000 +23,400	+114%	+$155K	﹤0.01%	3232
2026 Q1	$149K	Buy	+20,600	New	+$268K	﹤0.01%	3268

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GSK plc London $602M AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RAM

Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

HRT Financial's WVE Position: Q2 2026 in Review

HRT Financial sold out of Wave Life Sciences (WVE) in Q2 2026, closing a stake of 321,376 shares — an estimated $2.13M sold.

HRT Financial first reported a position in WVE in Q1 2021 and held it in 5 quarters. The position peaked at $5.09M in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

HRT Financial reported no remaining Wave Life Sciences position as of Q2 2026 after selling out during the quarter.
HRT Financial sold 321,376 Wave Life Sciences shares in Q2 2026, an estimated $2.13M.
HRT Financial first reported a position in Wave Life Sciences in Q1 2021 and held it in 5 quarters.
HRT Financial's Wave Life Sciences position peaked at $5.09M in Q4 2025.
239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.